FDA cleared the IND application for a clinical trial of the StealthX™ vaccine, funded by NIAID and conducted in collaboration with NIH and HHS.

The entities involved

• FDA →
  • Discussion on the limits of pharmacotherapy and the role of FDA approvals.20:19
  • Eton secures exclusive U.S. commercialization rights, with FDA acceptance driving the Anaphylm PDUFA date.18:33
• Capricor Therapeutics (United States) →

  company in Beverly Hills, United States

  Nothing else this week.

• National Institutes of Health →

  government organization in Shah Alam, Malaysia

  • The Office of Management and Budget proposes changes to federal funding policies affecting the National Institutes of Health.Tue 05:45
  • A research fellow at Mayo Clinic cited data from the National Institutes of Health in their statistics.Tue 00:59

Related events

• Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.Oct 22
• InflaRx is seeking discussions with the FDA and collaborating with Staidson BioPharmaceuticals on clinical trials.Tue 14:20
• NIH is funding research conducted by the National Cancer Institute (NCI) toward an FDA Investigational New Drug (IND) application.Oct 15
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Jun 7